Top

Quality of Life Research

Gepubliceerd in:

01-12-2009

Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale

Auteurs: Kitty S. Chan, Wen-Hung Chen, T. J. Gan, Ray Hsieh, Connie Chen, Mani Lakshminarayanan, Dennis A. Revicki

Gepubliceerd in: Quality of Life Research | Uitgave 10/2009

Abstract

Purpose

To develop and validate a composite score based on clinically meaningful events (CMEs) for the opioid-related symptom distress scale (OR-SDS) that would be appropriate for use in postoperative clinical trials.

Methods

Secondary analysis of data from 2 multi-site Phase III randomized clinical safety trials: a general surgery trial (N = 1,050) and a coronary artery bypass graft surgery trial (N = 1,636). Validating measures include daily opioid consumption and physician and patient global evaluations of study medication. We empirically defined CMEs for each symptom, using factor analysis and an area under the receiver-operating characteristic analysis of the severity and frequency items of the OR-SDS. Construct validity was examined by testing hypotheses of relationships between composite CME scores and opioid consumption and physician and patient evaluations of study medication.

Results

Hypotheses supporting the construct validity of the CME-based composite score were confirmed. Significant associations were found between higher numbers of CMEs with greater opioid consumption and lower likelihood of a positive evaluation of the study medication.

Conclusions

The OR-SDS CME-based composite score demonstrates evidence of construct validity and appears appropriate for use in evaluating patients’ opioid-related side effect burden in future postoperative clinical trials.

vorige artikel Determinants of overall quality of life in women over the first year after surgery for early stage breast cancer

volgende artikel Derivation and testing of an interval-level score for measuring locomotor disability in epidemiological studies of middle and old age

Wheeler, M., Oderda, G. M., Ashburn, M. A., & Lipman, A. G. (2002). Adverse events associated with postoperative opioid analgesia: A systematic review. The Journal of Pain, 3(3), 159–180.CrossRefPubMed

Aubrun, F., Monsel, S., Langeron, O., Coriat, P., & Riou, B. (2001). Postoperative titration of intravenous morphine. European Journal of Anaesthesiology, 18(3), 159–165.PubMed

Keita, H., Geachan, N., Dahmani, S., Couderc, E., Armand, C., Quazza, M., et al. (2003). Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement. British Journal of Anaesthesia, 90(1), 53–57.CrossRefPubMed

Zhao, S. Z., Chung, F., Hanna, D. B., Raymundo, A. L., Cheung, R. Y., & Chen, C. (2004). Dose-response relationship between opioid use and adverse effects after ambulatory surgery. Journal of Pain and Symptom Management, 28(1), 35–46.CrossRefPubMed

Zaheer, S., Reilly, W. T., Pemberton, J. H., & Ilstrup, D. (1998). Urinary retention after operations for benign anorectal diseases. Diseases of the Colon and Rectum, 41(6), 696–704.CrossRefPubMed

Apfelbaum, J. L., Gan, T. J., Zhao, S., Hanna, D. B., & Chen, C. (2004). Reliability and validity of the perioperative opioid-related symptom distress scale. Anesthesia and Analgesia, 99(3), 699–709. (Table of contents).CrossRefPubMed

Given, B., Given, C. W., Sikorskii, A., Jeon, S., McCorkle, R., Champion, V., et al. (2008). Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? Journal of Pain and Symptom Management, 35(2), 126–135.CrossRefPubMed

Nussmeier, N. A., Whelton, A. A., Brown, M. T., Joshi, G. P., Langford, R. M., Singla, N. K., et al. (2006). Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology, 104(3), 518–526.CrossRefPubMed

Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., et al. (2003). Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery, 125(6), 1481–1492.CrossRefPubMed

10.

Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326–1336.CrossRefPubMed

11.

Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Coyle, N., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3(3), 183–189.CrossRefPubMed

12.

Jöreskog, K. G., & Sörbom, D. (1985). LISREL VI: Analysis of linear structural relationships by maximum likelihood, instrumental variables, and least squares. Uppsala, Sweden: University of Uppsala.

13.

Bentler, P. M. (1989). EQS, structural equations: Program manual, program version 3.0. Los Angeles: BMDP Statistical Software, Inc.

14.

Gan, T. J., Joshi, G. P., Zhao, S. Z., Hanna, D. B., Cheung, R. Y., & Chen, C. (2004). Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects. Acta Anaesthesiologica Scandinavica, 48(9), 1194–1207.CrossRefPubMed

15.

Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36.PubMed

16.

Hanley, J. A., & McNeil, B. J. (1983). A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology, 148(3), 839–843.PubMed

17.

Diggle, P. J., Liang, K. Y., & Zeger, S. L. (1994). Analysis of longitudinal data. Oxford, UK: Clarendon Press.

18.

Shen, J., Barbera, J., & Shapiro, C. M. (2006). Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Medicine Reviews, 10(1), 63–76.CrossRefPubMed

Titel: Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale
Auteurs: Kitty S. Chan
Wen-Hung Chen
T. J. Gan
Ray Hsieh
Connie Chen
Mani Lakshminarayanan
Dennis A. Revicki
Publicatiedatum: 01-12-2009
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 10/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-009-9547-2

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 10/2009

Same question, different answers: a comparison of global health assessments using visual analogue scales

Derivation and testing of an interval-level score for measuring locomotor disability in epidemiological studies of middle and old age

Patient-reported outcomes instruments: bridging the gap between international copyright laws and common practice for developers and users—a case example

The association of body mass index and health-related quality of life in the general population: data from the 2003 Health Survey of England

The Oxford Ankle Foot Questionnaire for children: responsiveness and longitudinal validity

Determinants of overall quality of life in women over the first year after surgery for early stage breast cancer